72606-023 : Yuflyma 80 mg/.8ml Subcutaneous Injection


NDC: 72606-023
Labeler: Celltrion USA, Inc.
Product Type: Human Prescription Drug
Drug Name:  Yuflyma
Dosage Form: Subcutaneous Injection
Application #: BLA761219
Rev. Date: 


NDC Package Codes:

  • 72606-023-01: 1 SYRINGE, GLASS IN 1 CARTON (72606‑023‑01) / .8 ML IN 1 SYRINGE, GLASS
  • 72606-023-02: 1 SYRINGE, GLASS IN 1 CARTON (72606‑023‑02) / .8 ML IN 1 SYRINGE, GLASS
  • 72606-023-03: 2 SYRINGE, GLASS IN 1 CARTON (72606‑023‑03) / .8 ML IN 1 SYRINGE, GLASS
  • 72606-023-04: 1 SYRINGE, GLASS IN 1 CARTON (72606‑023‑04) / .8 ML IN 1 SYRINGE, GLASS
  • 72606-023-05: 2 SYRINGE, GLASS IN 1 CARTON (72606‑023‑05) / .8 ML IN 1 SYRINGE, GLASS
  • 72606-023-07: 3 SYRINGE, GLASS IN 1 CARTON (72606‑023‑07) / .8 ML IN 1 SYRINGE, GLASS
  • 72606-023-08: 3 SYRINGE, GLASS IN 1 CARTON (72606‑023‑08) / .8 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Adalimumab

Dosage Strength:

  • 80 mg/.8mL

Pharmaceutical Classes:

  • Antibodies
  • Monoclonal [CS]
  • Tumor Necrosis Factor Blocker [EPC]
  • Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Related Products:

Based on records with the same trade name.
  • 72606-024 Yuflyma 20 mg/.2ml Subcutaneous Injection by Celltrion USA, Inc.
  • 72606-030 Yuflyma 40 mg/.4ml Subcutaneous Injection by Celltrion USA, Inc.
  • 72606-039 YuflymaYuflyma Kit by Celltrion USA, Inc.
  • 72606-046 YuflymaYuflyma Kit by Celltrion USA, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72606-023 QR Code

< Prev: 72606-022Next: 72606-024 >

Related Discussions:

Humira (adalimumab) for pain
I’m on Humira (adalimumab) for RA joint pain and would like to know how other people are doing on it? I’m do... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.